P2T purinoceptors: ADP receptors on platelets

CIBA Foundation Symposia

Volumn , Issue 198, 1996, Pages 53-70

  Hourani, Susanna M O ^a   Hall, David A ^a,b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITY OF KENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; MEMBRANE PROTEIN; P2RY12 PROTEIN, HUMAN; PURINE P2 RECEPTOR; PURINE P2Y12 RECEPTOR;

ANIMAL; HUMAN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; THROMBOCYTE;

ADENOSINE DIPHOSPHATE; ANIMALS; BLOOD PLATELETS; HUMANS; MEMBRANE PROTEINS; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030338594     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Barnard EA, Burnstock G, Webb TE 1994 G protein-coupled receptors for ATP and other nucleotides: a new receptor family. Trends Pharmacol Sci 15:67-70
2. Born GVR 1962 Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927-929
3. Cattaneo M, Akkawat B, Lecchi A, Cimminiello C, Capitanio AM, Mannucci PB 1991 Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate. Thromb Haemostasis 66:694-699
4. Colman RJ 1992 Platelet ADP receptors stimulating shape change and inhibiting adenylate cyclase. News Physiol Sci 7:274-278
5. p diastereoisomers of adenosine 5′-O-(1-thiodiphosphate) on human platelets. Br J Pharmacol 73:409-412
6. Cusack NJ, Hourani SMO 1981b Partial agonist behaviour of adenosine 5′-O-(2-thiodiphosphate) on human platelets. Br J Pharmacol 73:405-408
7. Cusack NJ, Hourani SMO 1982a Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5′-monophosphate and adenosine 5′-triphosphate of human platelet aggregation induced by adenosine 5′-diphosphate. Br J Pharmacol 75:397-400
8. Cusack NJ, Hourani SMO 1982b Adenosine 5′-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors. Br J Pharmacol 76:221-227
9. Cusack NJ, Hourani SMO 1982c Competitive inhibition by adenosine 5′-triphosphate of the actions on human platelets of 2-chloroadenosine 5′-diphosphate, 2-azidoadenosine 5′-diphosphate and 2-methylthioadenosine 5′-diphosphate. Br J Pharmacol 77:329-333
10. 4- receptor. J Pharmacol Exp Ther 255:46-51
11. Gachet C, Cazenave JP 1991 ADP induced blood platelet activation: a review. Nouv Rev Fr Hematol 33:347-358
12. 1. Biochem Pharmacol 40:2683-2687
13. Gachet C, Cazenave JP, Ohlmann P, Hilf G, Wieland T, Jakobs KH 1992a ADP receptor-induced activation of guanine-nucleotide-binding proteins in human platelet membranes. Eur J Biochem 207:259-263
14. Gachet C, Savi P, Ohlmann P, Maffrand JP, Jakobs KH, Cazenave JP 1992b ADP receptor-induced activation of guanine nucleotide binding proteins in rat platelet membranes - an effect selectively blocked by the thienopyridine clopidogrel. Thromb Haemostasis 68:79-83
15. Gordon JL 1986 Extracellular ATP: effects, sources and fate. Biochem J 233:309-319
16. Hall DA 1993 The biochemical pharmacology of the human platelet ADP receptor. PhD thesis, University of Surrey, Guildford, Surrey, UK
17. 2T purinoceptors on human blood platelets. Br J Pharmacol 108:728-733
18. Hall DA, Hourani SMO 1994 Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5′-diphosphate in human platelets. Biochem Pharmacol 47:1013-1018
19. Hall DA, Frost V, Hourani SMO 1994 Effects of extracellular divalent cations on responses of human blood platelets to adenosine 5′-diphosphate. Biochem Pharmacol 48:1319-1326
20. Haslam RJ, Cusack NJ 1981 Blood platelet receptors for ADP and adenosine. In: Burnstock G (ed) Receptors & recognition series B, vol 12: Purinergic receptors. Chapman & Hall, London, p 221-285
21. Heemskerk JWM, Sage SO 1994 Calcium signalling in platelets and other cells. Platelets 5:295-316
22. Hourani SMO, Cusack NJ 1991 Pharmacological receptors on blood platelets. Pharmacol Rev 43:243-298
23. Hourani SMO, Hall DA 1994 ADP receptors on human blood platelets. Trends Pharmacol Sci 15:103-108
24. 2-purinoceptor antagonist suramin on human platelet aggregation induced by adenosine 5′-diphosphate. Br J Pharmacol 105:453-457
25. 2T-purinoceptor antagonist, FPL 67085, is a potent, efficacious and selective inhibitor of dynamic arterial thrombosis in the phenobarbitone-anaesthetized dog. Br J Pharmacol 113:63P(abstr)
26. 2T-purinoceptors. Br J Pharmacol 113:1057-1063
27. 2X purinoceptors be classified pharmacologically? Trends Pharmacol Sci 16:168-174
28. Kim BK, Zamecnik P, Taylor G, Guo MJ, Blackburn GM 1992 Antithrombotic effect of β,β-monochloromethylene diadenosine 5′,5‴-p1,p4-tetraphosphate. Proc Natl Acad Sci USA 90:5113-5117
29. 32P]diphosphate, an agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. J Clin Invest 71:420-428
30. 2U receptors on aortic endothelial cells. Br J Pharmacol 109:967-971
31. Rao AK, Kowalska MA 1987 ADP-induced platelet shape change and mobilization of cytoplasmic ionised calcium are mediated by distinct binding sites on platelets: 5′-p-fluorosulphonylbenzoyladenosine is a weak platelet agonist. Blood 70:751-756
32. Sage SO, Mahaut-Smith MP, Rink TJ 1992 Calcium entry in nonexcitable cells: lessons from human platelets. News Physiol Sci 7:108-113
33. Schrör K 1993 The basic pharmacology of ticlopidine and clopidogrel. Platelets 4:252-261
34. Siess W 1989 Molecular mechanisms of platelet activation. Physiol Rev 69:58-178
35. 2X receptors bring new structure to ligand-gated ion channels. Trends Neurosci 18:224-229